Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,beta vulgaris,biotin,colecalciferol,cyanocobalamin,cynara scolymus,dl-alpha-tocopheryl acetate,daucus carota,nicotinamide,pyridoxine hydrochloride,retinol palmitate,spinacia oleracea -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,beta vulgaris,biotin,colecalciferol,cyanocobalamin,cynara scolymus,dl-alpha-tocopheryl acetate,daucus carota,nicotinamide,pyridoxine hydrochloride,retinol palmitate,spinacia oleracea -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,beta vulgaris,biotin,calcium phosphate,colecalciferol,cyanocobalamin,cynara scolymus,dibasic magnesium phosphate trihydrate,dl-alpha-tocopheryl acetate,daucus carota,folic acid,lycopersicon esculentum,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,spinacia oleracea,thiamine nitrate,zinc oxide -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ascorbic acid,beta vulgaris,biotin,calcium phosphate,colecalciferol,cyanocobalamin,cynara scolymus,dibasic magnesium phosphate trihydrate,dl-alpha-tocopheryl acetate,daucus carota,folic acid,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,spinacia oleracea,thiamine nitrate,zinc oxide -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - cyanocobalamin, quantity: 0.75 microgram; ascorbic acid, quantity: 20 mg; potassium iodide, quantity: 0.0294 mg (equivalent: iodine, qty 22.5 microgram); dibasic magnesium phosphate trihydrate, quantity: 35.87 mg (equivalent: magnesium, qty 5 mg); daucus carota, quantity: 5 mg; cynara scolymus, quantity: 5 mg; spinacia oleracea, quantity: 5 mg; zinc sulfate heptahydrate, quantity: 4.444 mg (equivalent: zinc, qty 1 mg); beta vulgaris, quantity: 5 mg; nicotinamide, quantity: 6 mg; thiamine nitrate, quantity: 0.35 mg; biotin, quantity: 8.7 microgram; riboflavin, quantity: 0.125 mg; calcium phosphate, quantity: 13.33 mg (equivalent: calcium, qty 5 mg); pyridoxine hydrochloride, quantity: 608 microgram (equivalent: pyridoxine, qty 500 microgram); colecalciferol, quantity: 0.0025 mg; dl-alpha-tocopheryl acetate, quantity: 3.5 mg - pastille - excipient ingredients: malic acid; liquid glucose; purified water; medium chain triglycerides; sucrose; vegetable oil; gelatin; beetroot; carnauba wax; citric acid; maltodextrin; flavour; maize starch; acacia; potable water; calcium phosphate; dl-alpha-tocopherol; fractionated coconut oil; starch sodium octenyl succinate; silicon dioxide - maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support bone health

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - cyanocobalamin, quantity: 0.25 microgram; daucus carota, quantity: 5 mg; cynara scolymus, quantity: 5 mg; nicotinamide, quantity: 4.5 mg; retinol palmitate, quantity: 366 microgram (equivalent: vitamin a, qty 200 re); dl-alpha-tocopheryl acetate, quantity: 2.5 mg; ascorbic acid, quantity: 15 mg; beta vulgaris, quantity: 5 mg; spinacia oleracea, quantity: 5 mg; colecalciferol, quantity: 1.25 microgram; biotin, quantity: 37.5 microgram; pyridoxine hydrochloride, quantity: 608 microgram (equivalent: pyridoxine, qty 500 microgram) - pastille - excipient ingredients: sucrose; maltodextrin; gelatin; malic acid; glycerol; citric acid; carnauba wax; medium chain triglycerides; purified water; tomato; liquid glucose; vegetable oil; flavour - maintain/support healthy eye function ; maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support gum health ; maintain/support healthy teeth ; maintain/support bone health ; maintain/support skin health

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

nature's origins professional formulas - glutathione, quantity: 25 mg; schisandra chinensis, quantity: 50 mg (equivalent: schisandra chinensis, qty 250 mg); brassica oleracea var. italica, quantity: 90 mg; inositol, quantity: 25 mg; cynara scolymus, quantity: 20 mg (equivalent: cynara scolymus, qty 1 g; equivalent: caffeoylquinic acids calculated as cynarin of cynara scolymus, qty 1 mg); taraxacum officinale, quantity: 125 mg (equivalent: taraxacum officinale, qty 750 mg); brassica oleracea var. italica, quantity: 10 mg (equivalent: brassica olera - tablet, film coated - excipient ingredients: microcrystalline cellulose; maltodextrin; magnesium stearate; calcium hydrogen phosphate dihydrate; croscarmellose sodium; povidone; colloidal anhydrous silica; crospovidone; titanium dioxide; purified talc; triethyl citrate; sodium lauryl sulfate; methacrylic acid copolymer; sodium bicarbonate; indigo carmine aluminium lake; quinoline yellow aluminium lake; macrogol 4000; polyvinyl alcohol; lecithin; carmoisine aluminium lake - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support natural liver cleansing/detoxification processes ; maintain/support body metabolism/metabolic rate ; maintain/support general health and wellbeing ; maintain/support healthy digestive system function ; maintain/support healthy liver function

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sodium bicarbonate, quantity: 8.4 g - injection, intravenous infusion - excipient ingredients: disodium edetate; water for injections - 1. metabolic acidosis in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis where a rapid increase in plasma total co2 content is crucial. treatment of metabolic acidosis should be concurrent with measures designed to control the cause of the acidosis. 2.urinary alkalinisation in the treatment of certain drug intoxications (ie barbiturates, salicylates, lithium, methyl alcohol) and in the haemolytic reactions requiring alkalinisation of the urine to diminish nephrotoxicity of blood pigments. urinary alkalinisation is also used in methotrexate therapy to prevent nephrotoxicity. 3.severe diarrhoea which is often accompanied by a significant loss of bicarbonate.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lithium carbonate 250mg - capsule - 250 mg - active: lithium carbonate 250mg excipient: brilliant blue fcf gelatin lactose monohydrate magnesium stearate maize starch quinoline yellow sunset yellow fcf - · treatment of mania and hypomania. · treatment of some patients with recurrent bipolar depression, for which treatment with other antidepressants have been unsuccessful. · prophylactic treatment of recurrent affective disorders.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - sodium bicarbonate 8.4%;  ;   - solution for injection - 8.4 % - active: sodium bicarbonate 8.4%     excipient: disodium edetate sodium hydroxide - sodium bicarbonate is used as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates) to decrease renal absorption of the drug or to correct acidosis.